Lisinopril Market Size Was Valued at USD 1.5 Billion in 2023 and is Projected to Reach USD 2.3 Billion by 2032, Growing at a CAGR of 4.85% From 2024-2032.
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure (hypertension) and heart failure. By inhibiting the enzyme responsible for converting angiotensin I to angiotensin II, a potent...
Lisinopril, a widely used ACE (angiotensin-converting enzyme) inhibitor, is essential in the treatment of hypertension and heart failure. Its market has shown consistent growth due to increasing cardiovascular diseases and the expanding elderly population. This article delves into the current trends, key players, and future outlook of the lisinopril market.
Market Overview
The global lisinopril...
Lisinopril Market Size Was Valued at USD 1.5 Billion in 2023 and is Projected to Reach USD 2.3 Billion by 2032, Growing at a CAGR of 4.85% From 2024-2032.
Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure (hypertension) and heart failure. By inhibiting the enzyme responsible for converting angiotensin I to angiotensin II, a potent...
The WiseguyReports Lisinopril Market Report looks at the market's prospects for the future. It provides a comprehensive analysis of the following for the study year 2024–2032: key players, segments, growth, size, share, trends, and regional analysis. The study provides an analysis of the Lisinopril Market with market projections and estimates. The report contains two data points: revenue...